UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.
Evolve BioSystems, a US-based probiotics developer spun out of University of California (UC) Davis, reached the first close of a $55m series D round co-led by agricultural conglomerate Cargill.
Investment firm Manna Tree co-led the first tranche, the size of which was not disclosed and which also included Bow Capital, a venture capital firm anchored by University of California.
Medical products group Johnson & Johnson and food producer Campbell Soup participated through Johnson & Johnson Innovation – JJDC…
